Clinical Trials for Drug: Ibrutinib

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-14-93 UCReliance#1415_Phase 1b Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes in Previously Treated Patients or in Untreated Patients Unfit for or Who Refuse Intense Therapy Open